Drug Trial Radar · NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Dec 22, 2025
Primary completion
May 2029
Study completion May 2033
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Pfizer
- First posted
- Sep 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the efficacy and safety of the addition of Tersolisib (LY4064809/STX-478) to other anti-cancer drugs as first treatment for advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Participants can remain in the study as long as the drug is helping the cancer without unbearable side effects.
Conditions
- Breast Neoplasms
- Neoplasm Metastasis
Interventions
LY4064809Drug
Administered orally
PlaceboDrug
Administered orally
RibociclibDrug
Administered orally
PalbociclibDrug
Administered orally
AbemaciclibDrug
Administered orally
AnastrozoleDrug
Administered orally
LetrozoleDrug
Administered orally
ExemestaneDrug
Administered orally
FulvestrantDrug
Administered intramuscular
Primary outcomes
What the sponsor says the trial is designed to measure.
- (Part 1): Overall Response Rate (ORR): Percentage of Participants with Confirmed Complete Response (CR) or Partial Response (PR)Time frame: Baseline through disease progression or death (Estimated up to 5 years)
- (Part 2): Progression-Free SurvivalTime frame: Baseline to objective progression or death due to any cause (Estimated up to 5 years)
Locations
364 sites in 19 countries. Site status is shown where the registry gives one.
Alaska Oncology and Hematology
Anchorage, Alaska · Recruiting
Ironwood Cancer & Research Centers
Chandler, Arizona · Recruiting
St. Joseph's Hospital and Medical Center
Phoenix, Arizona · Not yet recruiting
Mayo Clinic in Arizona - Phoenix
Phoenix, Arizona · Not yet recruiting
The University of Arizona Cancer Center - North Campus
Tucson, Arizona · Recruiting
Genesis Cancer and Blood Institute
Hot Springs, Arkansas · Not yet recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
Community Cancer Institute
Clovis, California · Recruiting
City of Hope
Duarte, California · Recruiting
Epic Care - Emeryville
Emeryville, California · Recruiting
Marin Cancer Care
Greenbrae, California · Recruiting
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine
Irvine, California · Not yet recruiting
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California · Recruiting
USC/Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California · Not yet recruiting
Kaiser Permanente Oakland
Oakland, California · Not yet recruiting
Profound Research LLC
Oceanside, California · Recruiting
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California · Not yet recruiting
Desert Regional Medical Center
Palm Springs, California · Not yet recruiting
Stanford Cancer Center
Palo Alto, California · Recruiting
Kaiser Permanente
Roseville, California · Not yet recruiting
Kaiser Permanente
San Francisco, California · Not yet recruiting
Kaiser Permanente
Santa Clara, California · Not yet recruiting
UCLA Hematology/Oncology - Parkside
Santa Monica, California · Not yet recruiting
Providence Medical Foundation
Santa Rosa, California · Recruiting
Kaiser Permanente
Vallejo, California · Not yet recruiting
Kaiser Permanente Walnut Creek
Walnut Creek, California · Not yet recruiting
UCHealth Harmony
Fort Collins, Colorado · Not yet recruiting
Cancer Centers of Colorado St. Mary's Regional Hospital
Grand Junction, Colorado · Not yet recruiting
Banner MD Anderson Cancer Center at North Colorado Medical Center
Greeley, Colorado · Not yet recruiting
Banner MD Anderson Cancer Center at McKee Medical Center
Loveland, Colorado · Not yet recruiting
UConn Health
Farmington, Connecticut · Not yet recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Recruiting
AdventHealth Altamonte Springs
Altamonte Springs, Florida · Not yet recruiting
Clermont Oncology Center
Clermont, Florida · Recruiting
BRCR Global - Coral Springs
Coral Springs, Florida · Not yet recruiting
Florida Oncology & Hematology
Fort Myers, Florida · Recruiting
Mayo Clinic in Florida
Jacksonville, Florida · Not yet recruiting
University of Miami Hospital and Clinics, Sylvester Cancer Center
Miami, Florida · Not yet recruiting
Mid Florida Hematology and Oncology Center
Orange City, Florida · Recruiting
Showing 40 of 364 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.